The impact of increasing saline flush volume to reduce the amount of residual air
in the delivery system of aortic prostheses-a randomized controlled trial
Az orvos-, egészségtudományi- és gyógyszerészképzés tudományos műhelyeinek fejlesztése(EFOP-3.6.3-VEKOP-16-2017-00009)
Támogató: EFOP-VEKOP
Background Air embolism is a known risk during thoracic endovascular aortic repair
(TEVAR) and is associated with an incomplete deairing of the delivery system despite
the saline lavage recommended by the instructions for use (IFU). As the delivery systems
are identical and residual air remains frequently in the abdominal aortic aneurysm
sac, endovascular aortic repair (EVAR) can be used to examine the effectiveness of
deairing maneuvers. We aimed to evaluate whether increasing the flush volume can result
in a more complete deairing.Methods Patients undergoing EVAR were randomly assigned
according to flushing volume (Group A, 1x IFU; Group B, 4x IFU). The Terumo Aortic
Anaconda and Treo and Cook Zenith Alpha Abdominal stent grafts were randomly implanted
in equal distribution (10-10-10). The quantity of air trapped in the aneurysm sac
was measured using a pre-discharge computed tomography angiography (CTA). Thirty patients
were enrolled and equally distributed between the two groups, with no differences
observed in any demographic or anatomical factors.Results The presence of air was
less frequent in Group A compared to that in Group B [7 (47%) vs. 13 (87%), p = .02],
and the air volume was less in Group A compared to that in Group B (103.5 +/- 210.4
vs. 175.5 +/- 175.0 mm3, p = .04). Additionally, the volume of trapped air was higher
with the Anaconda graft type (p = .025).Discussion These findings suggest that increased
flushing volume is associated with a higher amount of trapped air; thus, following
the IFU might be associated with a reduced risk of air embolization. Furthermore,
significant differences were identified between devices in terms of the amount of
trapped air.Clinical trial registration [NCT04909190], [ClinicalTrials.gov].